Abstract
AbstractCholangiocarcinoma is a rare, aggressive biliary tract malignancy representing only 3% of digestive cancers worldwide. Late diagnosis is common, which results in less than one-third of patients being eligible for surgical resection or liver transplantation. Surgery, however, is not without associated morbidity and mortality. This article seeks to review minimally invasive techniques for the management of complications following liver transplantation and hepatic resection for patients with cholangiocarcinoma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
